Investment Q&A

Q: KXS had a media day yesterday, do you know if they did an update on the contract with Toyota? To me that is likely a "company maker" deal. I have been after them for an update (since the deal was announced two months ago) but their IR department seems to think that is some sort of "state secret" and just read off a scripted non answer that said absolutely nothing when I contacted them.

Do you by any chance have more information to share on the Toyota deal? Thanks.

Q: Would you recommend this company as a buy at this time? Is there a price level at which you would consider it a buy?
There is some speculation that Shopify will be adversely affected due to its business relations with Facebook and the troubles that they are having.

Q: Ceo cancelled scheduled appearance on BNN to answer allegations of "short attack" Why? Stock continue slide,& 5.2% today.Your opinion please.Txs for u usual great services & views

Q: Your thought on RHT at current price?

Q: KXS was down about 5% over the last two
days. Does this have anything to do with their investor day yesterday? Thanks
Ed

Q: What is your take on ET and future prospects.
What is their technology and are they staying in the lead with this?
Any takeover chances?
Do you talk to management?

Q: both of these companies have been getting killed especially covalon,maybe covalons mediclear is not getting the acceptance it wants, and they are at a conference this week where they are promoting mediclear, as for reliq i know it is still up a lot but lately also gettng killed.can you comment.
dave

Q: This one is crashing too.
Are all these small caps pump and dumb?

Q: I was wondering if you have comments on the recent Citron report re: Shop. Any valid concerns in your view?

Q: Kinaxis had an Investor day on Tuesday March 27.
Does the drop of 2.56% have anything to do with any comments made by management during this session?
Thanks for your info.
Albert

Q: Why is this crashing?

Q: Any concerns about BYD being down, on much higher than average volume, on a day almost everything else was up? Any news that drove the volume and/or price?

Q: What is your view on JCP Issues Letter to Unitholders of Crius Energy Trust.

Tx

Q: Hi Team, have some cash to deploy and I would just be rounding off my sectors.
Is there any name you would not buy today in the Balanced Equity Portfolio.
Thank-you in advance. Sam

Q: Hi Team,
Your thought on COV, since they drop some 30% form the high. Is it worth to add on more or let it go and move on.
Thank you and appreciate as always.
Tak

Q: your advice on this stock after their poor statement for last quarter--thanks for all your help--Francis

Q: What do you consider be a successful auction? Please provide exemple of good and bad auction. Is it based on price or the willingness to shareshoders to let go shares!!!

Tx

Q: What are your thoughts on CEO Don Walker and COO Tommy Skudutis disposing of a fairly large block of shares this week? Cause for concern?

Q: Q: What are your thoughts on ECN? Is it a reasonable buy at this time? Are the dividends of the prefered shares, series A and C reasonably safe? I very much appreciate your expertise and insight.

Howard

Q: So I'm at the point where our rrsp will be in withdrawals-mode to fund our living expenses moving forward and therefore a shift from the balanced portfolio to income seems appropriate. There is no urgency in this shift however. With the income portfolio down around 5% year to date do you think this is a good time to begin this process in earnest. Would your recommendation be to move gradually into the income names from the balanced equity names or to "just do it." Also we have an increase in cash coming from mortgage investments in our rrsp's being paid off over the next 18 months. Would you recommend buying the income portfolio names as the cash arrives or some more staggered approach. I know you don't have a crystal ball and that you might suggest this is an individual choice for us to make but nonetheless I am seeking YOUR call on these 2 issues. I appreciate your input.